RTW Investments portfolio
35 tracked investments, 11 on the map, $2.5B raised across the mapped portfolio.
RTW Investments35 investments · 11 on the map · $2.5B raised- Rocket PharmaceuticalsPost-IPO Equity
- UroGen PharmaPost-IPO Equity
- Milestone PharmaceuticalsPost-IPO Debt
- Stoke TherapeuticsSeries B
- LENZ THERAPEUTICSPost-IPO Equity
- Magnolia Medical TechnologiesPrivate Equity
- Verastem OncologyPost-IPO Equity
- CORXEL PharmaceuticalsSeries D
- REGENXBIOSeries D
- Allakos
- Lycia Therapeutics
Also in the portfolio
- Apogee Therapeutics
- Orchestra BioMed
- Aktis Oncology
- Biomea Fusion
- Dianthus Therapeutics
- CinCor Pharma
- AIRNA
- Avidity Biosciences
- Establishment Labs
- Zai Lab
- NeoGenomics
- Third Harmonic Bio
- Yarrow
- Arvinas
- Savara Pharmaceuticals
- Avadel Pharmaceuticals
- Cullinan Therapeutics
- Taysha Gene Therapies
- Kalaris Therapeutics (formerly AlloVir)
- Pulmonx
- ITeos Therapeutics
- Neurogastrx
Investors similar to RTW Investments
RA Capital Management150 investments · 92 on the map · $6.7B raised
Sectoral Asset Management23 investments · 6 on the map · $2.1B raised
Redmile Group61 investments · 14 on the map · $5.4B raised
Alexandria Venture Investments72 investments · 14 on the map · $3B raised
Perceptive Advisors109 investments · 13 on the map · $4.4B raised
Janus Henderson Investors70 investments · 11 on the map · $4.1B raised